Back to search

What is the value of hemoglobin as a prognostic and predictive factor in cancer?

Data up to Jan 2025

Published2004
Citations13
References45

Total Citations Per Year

Abstract

References (45)

Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects

2001 • 2,558 citations

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

1999 • 1,782 citations

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

1996 • 1,747 citations

A Prognostic Score for Advanced Hodgkin's Disease

1998 • 1,694 citations

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

2001 • 828 citations

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

1991 • 732 citations

Anemia as an independent prognostic factor for survival in patients with cancer

2001 • 698 citations

Treatment Resistance of Solid Tumors

2001 • 533 citations

Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy

2001 • 446 citations

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1999 • 430 citations

Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes

2002 • 364 citations

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

1997 • 267 citations

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

2001 • 264 citations

Mantle cell lymphoma: a retrospective study of 121 cases

1998 • 205 citations

Anaemia in cancer: pathophysiology and treatment

2000 • 202 citations

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

2001 • 188 citations

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases

2000 • 186 citations

Localized Childhood Hodgkin’s Disease: Response-Adapted Chemotherapy With Etoposide, Bleomycin, Vinblastine, and Prednisone Before Low-Dose Radiation Therapy—Results of the French Society of Pediatric Oncology Study MDH90

2000 • 155 citations

Tumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy

1998 • 122 citations

Frequency and significance of anemia in non-Hodgkin’s lymphoma patients

1998 • 99 citations

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

1999 • 98 citations

Biological basis of anemia

2001 • 96 citations

THE TREATMENT OF MULTIPLE MYELOMA

1948 • 92 citations

Impact of Anemia in Patients With Head and Neck Cancer

2000 • 84 citations

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities

2000 • 84 citations

The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience

2001 • 77 citations

Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma

2001 • 76 citations

Significant Prognostic Factors for 5‐Year Survival after Curative Resection of Renal Cell Carcinoma

1998 • 51 citations

A prognostic score for hormone-refractory prostate cancer: analysis of two cancer and leukemia group B studies.

1999 • 49 citations

Treatment of multiple myeloma

1999 • 39 citations

ANÆMIA IN CANCER

1965 • 38 citations

Epoetin in cancer-related anaemia

1999 • 38 citations

Erythropoiesis and Erythropoietin in Multiple Myeloma

1995 • 37 citations

Prognostic Factors for Survival in Inoperable Non-Small-Cell Lung Cancer: A Multivariate Regression Analysis of 456 Patients with Radiation Therapy

1997 • 35 citations

Prognostic Value of Hemoglobin Concentrations in Patients with Advanced Head and Neck Cancer Treated with Combined Radio-Chemotherapy and Surgery

2000 • 34 citations

Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer.

2000 • 33 citations

PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.

1997 • 32 citations

Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer.

2000 • 31 citations

Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.

2002 • 27 citations

Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma.

1995 • 26 citations

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

1998 • 24 citations

Erythropoietin for the treatment of anemia associated with hematological malignancy

2001 • 23 citations

Überlebenszeiten ausschließlich bestrahlter NSCLC-Patienten

1998 • 22 citations

Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL).

1998 • 12 citations

Cited By (0)

Loading...
What is the value of hemoglobin as a prognostic and predictive factor in cancer? (2004) – European Journal of Cancer Supplements | Metascience Observatory Explorer